| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.04. | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | 102 | GlobeNewswire (Europe) | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| 16.04. | French MND group launches ORIZON, its new range of detachable cable transport equipment for mobility in mountain, tourist and urban environments | 217 | PR Newswire | GRENOBLE, France, April 16, 2024 /PRNewswire/ -- French industrial group MND, a major cable transport player, today unveiled ORIZON, its new range of cable transport solutions (gondolas and... ► Artikel lesen | |
| 16.04. | Die französische MND-Gruppe bringt ORIZON auf den Markt, ihre neue Produktreihe von kuppelbaren Seilbahnanlagen für die Mobilität in den Bergen, in touristischen Gebieten und im städtischen Umfeld | 43 | PR Newswire | GRENOBLE, Frankreich, 16. April 2024 /PRNewswire/ -- Der französische Industriekonzern MND, ein wichtiger Akteur im Bereich des Seilbahnwesens, hat heute ORIZON vorgestellt, seine neue Produktreihe... ► Artikel lesen | |
| 10.04. | PharmAust inks approval from Macquarie University for Open-Label MND extension study | 5 | Stockhead | ||
| 10.04. | PharmAust's pioneering monepantel MND study receives HREC green light for final phase | 2 | smallcaps.com.au | ||
| 10.04. | PHARMAUST LIMITED: Final Ethics Approval for Open-Label MND Extension Study | - | ASX | ||
| 04.04. | MONADELPHOUS GROUP LIMITED: Notification of cessation of securities - MND | - | ASX | ||
| 04.04. | MONADELPHOUS GROUP LIMITED: Notification of cessation of securities - MND | - | ASX | ||
| 04.04. | MONADELPHOUS GROUP LIMITED: Notification of cessation of securities - MND | - | ASX | ||
| 01.04. | Should You Open a Position in monday.com (MNDY)? | 7 | Insider Monkey | ||
| 28.03. | MONADELPHOUS GROUP LIMITED: Application for quotation of securities - MND | 1 | ASX | ||
| 25.03. | MONADELPHOUS GROUP LIMITED: Update - Dividend/Distribution - MND | 1 | ASX | ||
| 18.03. | (MNDY) - Analyzing Monday.Com's Short Interest | 2 | Benzinga.com | ||
| 14.03. | 'Miracle' app helped me find voice again - MND sufferer | 1 | RTE.ie | ||
| 14.03. | PharmAust files groundbreaking MND/ALS clinical data with the FDA | 6 | Stockhead | ||
| 14.03. | PharmAust eyes FDA orphan drug designation for monepantel after positive MND/ALS trial results | 4 | smallcaps.com.au | ||
| 29.02. | (MNDY) - Analyzing Monday.Com's Short Interest | 4 | Benzinga.com | ||
| 28.02. | PharmAust Limited: PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS | 196 | PR Newswire | Highlights:
Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio®
Preliminary efficacy data shows a 58% reduction in the rate of disease progression for Cohort... ► Artikel lesen | |
| 28.02. | PharmAust's MPL could offer MND/ALS patients up to 56.5 months additional life expectancy | 5 | Stockhead | ||
| 28.02. | PharmAust's monepantel study shows 58% slowdown in MND progression | 3 | smallcaps.com.au |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 3.263 |
| SUPER MICRO COMPUTER | 2.399 |
| BYD | 2.031 |
| BAYER | 1.929 |
| NVIDIA | 1.449 |
| NEL | 1.291 |
| DEUTSCHE BANK | 1.217 |
| TUI | 1.198 |
| APPLE | 1.195 |
| TESLA | 1.125 |
| AMAZON | 950 |
| MERCEDES-BENZ | 869 |
| VOLKSWAGEN | 817 |
| COMMERZBANK | 756 |
| NOVO NORDISK | 748 |
| PLUG POWER | 747 |
| PFIZER | 721 |
| AIXTRON SE | 719 |
| HUGO BOSS | 648 |
| PAYPAL | 616 |
| CANOPY GROWTH | 610 |
| RHEINMETALL | 595 |
| DEUTSCHE LUFTHANSA | 585 |
| AMD | 584 |
| BIONTECH | 583 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
